(Q33380278)

26 July 2017

title

Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk (English)

1 reference

26 July 2017

1 reference

1 reference

10

Markolf Hanefeld

1 reference

26 July 2017

3

Andreas Pfützner

1 reference

26 July 2017

Thomas Forst

1

1 reference

26 July 2017

Birgit Wilhelm

2

1 reference

26 July 2017

Winfried Fuchs

4

1 reference

26 July 2017

Ute Lehmann

5

1 reference

26 July 2017

Frank Schaper

6

1 reference

26 July 2017

Matthias Weber

7

1 reference

26 July 2017

Jürgen Müller

8

1 reference

26 July 2017

Thomas Konrad

9

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

Diabetes and Vascular Disease Research

26 July 2017

published in

1 reference

26 July 2017

volume

5

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

298-303

1 reference

Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Pioglitazone: an antidiabetic drug with the potency to reduce cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Habitual physical activity and vascular aging in a young to middle-age population at low cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Increased arterial augmentation and augmentation index as surrogate parameters for arteriosclerosis in subjects with diabetes mellitus and nondiabetic subjects with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mellitus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Adiponectin: protection of the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality: an 11-year follow-up of the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Effect of pioglitazone on blood proinsulin levels in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Pharmacological PPARgamma stimulation in contrast to beta cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

Effect of Rosiglitazone on Endothelial Function and Inflammatory Markers in Patients With the Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2008.043

21 January 2018

Identifiers

DOI

10.3132/DVDR.2008.043

1 reference

26 July 2017

1 reference